Website cover 3.png
Molécula Sola.png
_MG_4698-2.jpg
Website cover 3.png

Home


Combining the latest advances in nanotechnology and microRNA-based therapeutics to fight cancer

SCROLL DOWN

Home


Combining the latest advances in nanotechnology and microRNA-based therapeutics to fight cancer

Molécula Sola.png

Hike


Speratum is a medical research venture launching a first-of its class, patented treatment for pancreatic cancer.  Our technology can target the molecular pathways  that give rise to pancreatic cancer aggressiveness, reducing tumor spread and metastasis

Hike


Speratum is a medical research venture launching a first-of its class, patented treatment for pancreatic cancer.  Our technology can target the molecular pathways  that give rise to pancreatic cancer aggressiveness, reducing tumor spread and metastasis

_MG_4698-2.jpg

End


Our lead product is a patent-protected, specific microRNA treatment discovered at Baylor College of Medicine in Houston, TX, that acts as a central regulator of pancreatic cancer. We have demonstrated that we can stop tumor growth and metastasis in vitro and in vivo.

 

We are currently conducting IND-enabling pre-clinical efficacy and toxicology studies to take our product to the clinic.  

 

We are currently developing a number of additional therapeutic, delivery, and diagnostic applications which are in the discovery and testing phase. 

 

End


Our lead product is a patent-protected, specific microRNA treatment discovered at Baylor College of Medicine in Houston, TX, that acts as a central regulator of pancreatic cancer. We have demonstrated that we can stop tumor growth and metastasis in vitro and in vivo.

 

We are currently conducting IND-enabling pre-clinical efficacy and toxicology studies to take our product to the clinic.  

 

We are currently developing a number of additional therapeutic, delivery, and diagnostic applications which are in the discovery and testing phase.